Barely Significant
← all excerpts

Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives.

Vasc Health Risk Manag · 2009 · PMC2686256 · PMID 19475775

Europe PMCDOI
3
hedged sentences
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

failed to reach significancep = 0.07so close (0.05 < p ≤ 0.1)
The risk reduction between the treatment groups (11%) in the primary endpoint of major coronary events failed to reach significance (p = 0.07).

also in 3,767 other papers

highly significantno p-value reported
7 The CARDS study was terminated after approximately two years early due to the highly significant reduction in cardiovascular events, including heart attack and stroke, in those patients receiving atorvastatin treatment.

also in 127,188 other papers

near-significantno p-value reported
8 However, amlodipine was associated with a statistically significant 16% reduction in the incidence of myocardial infarction and a near-significant reduction in stroke ( Table 1 ).

also in 2,240 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.